Related Experiment Video
Updated: May 18, 2026

07:00
Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019
Nasal hemangiopericytoma causing oncogenic osteomalacia
Sung Il Cho1, Nam Yong Do, Seung Woo Yu
1Department of Otorhinolaryngology, Chosun University College of Medicine, Gwangju, Korea.
Clinical and Experimental Otorhinolaryngology
|September 15, 2012
Summary
A rare nasal hemangiopericytoma caused oncogenic osteomalacia in a 47-year-old woman. Surgical removal of the tumor resolved her bone metabolism abnormalities and relieved symptoms.
Area of Science:
- Endocrinology
- Oncology
- Pathology
Background:
- Oncogenic osteomalacia is a rare paraneoplastic syndrome causing bone metabolism abnormalities.
- Nasal hemangiopericytoma is an uncommon tumor, rarely associated with systemic effects.
Purpose of the Study:
- To report a rare case of nasal hemangiopericytoma causing oncogenic osteomalacia.
- To review the literature on this rare association.
Main Methods:
- Surgical excision of a nasal mass.
- Histopathological diagnosis of hemangiopericytoma.
- Monitoring of biochemical markers for bone metabolism.
Main Results:
- A 47-year-old woman presented with a nasal mass and osteomalacia.
- Post-excision, the mass was diagnosed as hemangiopericytoma.
- Patient's osteomalacia symptoms and biochemical abnormalities resolved after surgery.
Conclusions:
- Nasal hemangiopericytoma can manifest as oncogenic osteomalacia.
- Surgical resection is an effective treatment for this condition.
- Early diagnosis and intervention are crucial for favorable outcomes.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...